|
Sign In to gain access to subscriptions and/or personal tools.
|
A Prospective, Randomized Clinical Trial on Perioperative Feeding With an Arginine-, Omega-3 Fatty Acid-, and RNA-Enriched Enteral Diet: Effect on Host Response and Nutritional Status
Luca Gianotti, MD, ScD
Department of Surgery, S. Luigi Center, Scientific Institute S. Raffaele Hospital
Marco Braga, MD
Department of Surgery, S. Luigi Center, Scientific Institute S. Raffaele Hospital
Claudio Fortis, MD
Department of Infectious Diseases, S. Luigi Center, Scientific Institute S. Raffaele Hospital
Laura Soldini, MD
Department of Laboratory Medicine, S. Luigi Center, Scientific Institute S. Raffaele Hospital
Andrea Vignali, MD
Department of Surgery, S. Luigi Center, Scientific Institute S. Raffaele Hospital
Stefania Colombo, MS
Department of Laboratory Medicine, S. Luigi Center, Scientific Institute S. Raffaele Hospital
Giovanni Radaelli, PhD
Department of Informative Systems, University of Milan, Italy
Valerio Di Carlo, MD
Department of Surgery, S. Luigi Center, Scientific Institute S. Raffaele Hospital
Background: The use of immune-enhancing enteral diets in the postoperative period has given contrasting results. The purpose of this prospective, randomized, double-blinded clinical study was to evaluate the effect of immunonutrition given perioperatively on cytokine release and nutritional parameters. Methods: Patients with cancer of the stomach or colo-rectum were eligible. Subjects consumed 1 L/d of either a control enteral formula (n = 25; control group) or a formula supplemented with arginine, omega-3 fatty acids, and RNA (n = 25; verum group) for 1 week before surgery. Both formulas were given by mouth. Six hours after the operation, jejunal infusion with the same diets was started and maintained for 7 days. Blood was drawn at different time points to assess albumin, prealbumin (PA), transferrin, cholinesterase activity, retinol binding protein (RBP), interleukin-2 receptors alpha (IL-2R ), IL-6, and IL-1 soluble receptors (IL-1RII). The composite score of delayed hypersensitivity response (DHR) to skin test also was determined (the higher the score, the lower the immune response). Results: During the 7 days of presurgical feeding, none of the above parameters changed in either group. Eight days after operation, in the control group, the concentration of PA and RBP was lower than in the verum group (0.18 us 0.26 g/L for PA and 30.5 us 38.7 mg/L for RBP; p < .05). IL-2R concentration was 507 pg/mL in the verum group us 238 pg/mL in the control group (p < .001), whereas IL-6 and IL-1RII were higher in the control group than in the verum group (104 us 49 and 328 us 183 pg/mL, respectively; p < .01). The DHR score was 0.68 in the control group us 0.42 in the verum group (p < .05). Conclusions: Perioperative feeding with a supplemented enteral diet modulates cytokine production and enhances cell-mediated immunity and the synthesis of short half-life proteins. (Journal of Parenteral and Enteral Nutrition 23:314-320, 1999)
Journal of Parenteral and Enteral Nutrition, Vol. 23, No. 6,
314-320 (1999)
DOI: 10.1177/0148607199023006314

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. M. Wiese, R. Rivera, and D. L. Seidner
Is There a Role for Bowel Rest in Nutrition Management of Crohn's Disease?
Nutr Clin Pract,
June 1, 2008;
23(3):
309 - 317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Braga and L. Gianotti
Preoperative Immunonutrition: Cost-Benefit Analysis
JPEN J Parenter Enteral Nutr,
January 1, 2005;
29(1_suppl):
S57 - S61.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Farber, J. Moses, and M. Korn
Reducing Costs and Patient Morbidity in the Enterally Fed Intensive Care Unit Patient
JPEN J Parenter Enteral Nutr,
January 1, 2005;
29(1_suppl):
S62 - S69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Jho, S. M. Cole, E. M. Lee, and N. J. Espat
Role of Omega-3 Fatty Acid Supplementation in Inflammation and Malignancy
Integr Cancer Ther,
June 1, 2004;
3(2):
98 - 111.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R F Grimble
Nutritional therapy for cancer cachexia
Gut,
October 1, 2003;
52(10):
1391 - 1392.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C McCowen and B. R Bistrian
Immunonutrition: problematic or problem solving?
Am. J. Clinical Nutrition,
April 1, 2003;
77(4):
764 - 770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Duggan, J. Gannon, and W A. Walker
Protective nutrients and functional foods for the gastrointestinal tract
Am. J. Clinical Nutrition,
May 1, 2002;
75(5):
789 - 808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Braga, L. Gianotti, L. Nespoli, G. Radaelli, and V. Di Carlo
Nutritional Approach in Malnourished Surgical Patients: A Prospective Randomized Study
Arch Surg,
February 1, 2002;
137(2):
174 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Heyland, F. Novak, J. W. Drover, M. Jain, X. Su, and U. Suchner
Should Immunonutrition Become Routine in Critically Ill Patients?: A Systematic Review of the Evidence
JAMA,
August 22, 2001;
286(8):
944 - 953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gianotti
Response to Dr Buchman
JPEN J Parenter Enteral Nutr,
November 1, 2000;
24(6):
367 - 368.
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Buchman
Nutritional Supplements: Is it the "Immuno" or the "Nutrition" that Is Important?
JPEN J Parenter Enteral Nutr,
November 1, 2000;
24(6):
367 - 367.
[PDF]
|
 |
|
|
|